COVID-19 Pill

Biological Drug Manufacturing
Biopharmaceuticals
Biotechnology
Cancer
Cancer Biopharmaceuticals
Cash
Coronavirus
COVID-19
COVID-19 Pill
Defensive Stocks
Dividend Stocks
Dividend Yields
Dividends
Drug Development
Fibonacci Retracement
Free Cash Flow
Fundamental Analysis
Fundamentals
InvestivDaily
Oncology
Pharmaceuticals
Technical Analysis
Valuations
Value Investing

MRK is up about 14% from its December low. Is it a good time to buy?

As I’ve studied the market over the years, one of the intriguing contrasts comes in the way different analysis methods take in the “big picture” of the market. That includes the way that fundamental investors and analysts look at the market versus those that prefer to work on strictly technical terms. I like to work […]

Read More
COVID-19
COVID-19 Pill
MRNA Vaccines
Novel Vaccines
Vaccines

Pfizer’s Covid Pill Is Shaking Up the Global Recovery Trade

(Bloomberg) — Shares tied to reopening trades from casinos to airlines surged in Asia on Monday after Pfizer Inc. said that its Covid-19 pill could reduce hospitalizations and deaths in high-risk patients by 89%. A Bloomberg gauge of Macau casino shares jumped 7.2%, the biggest move in over two months, while an index of Asia-Pacific […]

Read More

  

X